| 361 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 362 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 363 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 364 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 365 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 366 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 367 |
spectrum of epilepsy–prevalence, impact, and treatment gap: an epidemiological study from al-Quseir, egypt |
2016 |
| 368 |
Steroid/Antiviral for the treatment of Bell’s
palsy: Double blind randomized clinical trial |
2016 |
| 369 |
Steroid/Antiviral for the treatment of Bell’s
palsy: Double blind randomized clinical trial |
2016 |
| 370 |
Steroid/Antiviral for the treatment of Bell’s
palsy: Double blind randomized clinical trial |
2016 |
هل لديك سؤال ؟
